Blackbaud Reports Strong FY25 Results, Issues Robust 2026 Guidance, and Expands $1B Stock Buyback
Summary
Blackbaud announced strong fourth quarter and full-year 2025 financial results, driven by non-GAAP organic revenue growth and improved profitability, while also providing robust 2026 guidance and expanding its stock repurchase program.
Key Events
-
Reports Strong FY25 Performance
Achieved 5.5% non-GAAP organic revenue growth and a 41.4% Rule of 40 score for the full year 2025, demonstrating a healthy balance of growth and profitability.
-
Issues Robust 2026 Financial Guidance
Provided optimistic full-year 2026 guidance, projecting significant increases in non-GAAP adjusted EBITDA ($430M-$438M), diluted EPS ($5.15-$5.25), and free cash flow ($280M-$290M).
-
Expands $1 Billion Stock Repurchase Program
Reauthorized and expanded its stock repurchase program to $1 billion, with plans to repurchase 5.0% to 10.0% of outstanding common stock in 2026, signaling a strong commitment to shareholder returns.
Analysis
Blackbaud's latest earnings report highlights a solid operational performance in 2025, marked by healthy non-GAAP organic revenue growth and improved non-GAAP operating margins, leading to the achievement of the Rule of 40 two years ahead of schedule. While GAAP revenue saw a slight decline due to a prior divestiture, the underlying business appears strong. The company's 2026 financial guidance is particularly positive, projecting significant growth in non-GAAP adjusted EBITDA, diluted EPS, and free cash flow, which should instill investor confidence. Furthermore, the reauthorized and expanded $1 billion stock repurchase program, with plans to buy back 5-10% of outstanding shares in 2026, signals a strong commitment to returning capital to shareholders and could provide significant support for the stock. Investors should monitor the execution of this guidance and the impact of the share repurchase program.
At the time of this filing, BLKB was trading at $50.35 on NASDAQ in the Technology sector, with a market capitalization of approximately $2.3B. The 52-week trading range was $45.81 to $81.39. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.